May 5, 2010: American Peptide Company, a provider of peptides and peptide-based services to the pharmaceutical and biotech industries, has ramped up its cGMP peptide manufacturing capabilities as well as its service offerings to provide viable peptide-based solutions to speed time-to-market.
The company’s expansion of its Vista, California, USA facility allows it to process large-scale innovative peptide production needs. The facility expansion includes three main areas: purification, synthesis and lyophilisation. Four new peptide purification suites have been added for large-scale purification projects. Construction of two new synthesis suites, both for solution phase and solid phase will be planned. Another tray will be added to the company’s lyophilisation capacity to enable release of multi-kilo single batches of peptide APIs.
In addition to the expansion of its manufacturing capabilities, the company offers its Total Peptide Management™ programme to provide increased regulatory support and value-added services. The programme offers a broad portfolio of peptides, and expert consultation to support customer needs as drug products move from discovery to development and commercialisation.
